SAMHD1-dependent and -independent functions of HIV-2/SIV Vpx protein

Frontiers in Microbiology

Volumn 3, Issue AUG, 2012, Pages

  Fujita, Mikako ^a   Nomaguchi, Masako ^b   Adachi, Akio ^b   Otsuka, Masami ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

dNTP; HIV 2; Nuclear import,Vpr; Reverse transcription; SAMHD1; SIV; Vpx

Indexed keywords

EID: 84874715002     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00297     Document Type: Review

References (61)

1. Agostini, I., Popov, S., Hao, T., Li, J. H., Dubrovsky, L., Chaika, O., Chaika, N., Lewis, R., and Bukrinsky, M. (2002). Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. AIDS Res. Hum. Retroviruses 18, 283-288.
2. Ahn, J., Hao, C., Yan, J., DeLucia, M., Mehrens, J., Wang, C., Gronenborn, A. M., and Skowronski, J. (2012). HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J. Biol. Chem. 287, 12550-12558.
3. Akari, H., Sakuragi, J., Takebe, Y., Tomonaga,K.,Kawamura,M.,Fukasawa, M., Miura, T., Shinjo, T., and Hayami, M. (1992). Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Arch. Virol. 123, 157-167.
4. Andrew,A.,and Strebel,K. (2010). HIV1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms. Mol. Aspects Med. 31, 407-417.
5. Arias, J. F., Iwabu, Y., and Tokunaga, K. (2011). Structural basis for the antiviral activity of BST2/tetherin and its viral antagonism. Front. Microbiol. 2:250. doi:10.3389/fmicb.2011.00250
6. Belshan, M., Kimata, J. T., Brown, C., Cheng, X., McCulley, A., Larsen, A., Thippeshappa,R.,Hodara,V.,Giavedoni, L., Hirsch, V., and Ratner, L. (2012). Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology 9, 32.
7. Bergamaschi, A., Ayinde, D., David, A., Le Rouzic, E., Morel, M., Collin, G., Descamps, D., Damond, F., BrunVezinet, F., Nisole, S., MargottinGoguet, F., Pancino, G., and Transy, C. (2009). The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J. Virol. 83, 4854-4860.
8. Berger, A., Münk, C., Schweizer, M., Cichutek, K., Schüle, S., and Flory, E. (2010). Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 fam-ily member A (APOBEC3A) corre-lates with efficient lentivirus infec-tion of monocytes. J. Biol. Chem. 285, 12248-12254.
9. Berger, G., Durand, S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.-L., and Cimarelli, A. (2011). APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7, e1002221. doi:10.1371/journal.ppat.1002221
10. Brandariz-Nuñez, A., Valle-Casuso, J. C., White, T. E., Laguette, N., Benkirane, M., Brojatsch, J., and Diaz-Griffero, F. (2012). Roles of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology 9, 49.
11. Di Marzio, P., Choe, S., Ebright, M., Knoblauch, R., and Landau, N. R. (1995). Mutational analysis of cell cycle arrest, nuclear localization,and virion packaging of human immun-odeficiency virus type 1 Vpr. J. Virol. 69, 7909-7916.
12. Diamond, T. L., Roshal, M., Jamburuthugoda, V. K., Reynolds, H. M., Merriam, A. R., Lee, K. Y., Balakrishnan, M., Bambara, R. A., Planelles, V., Dewhurst, S., and Kim, B. (2004). Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem. 279, 51545-51553.
13. Doi, N., Fujiwara, S., Adachi, A., and Nomaguchi, M. (2011). Rhesus M1.3S cells suitable for biological evaluation of macaque-tropic HIV/SIV clones. Front. Microbiol. 2:115. doi:10.3389/fmicb.2011.00115
14. Fletcher, T. M. III, Brichacek, B., Sharova, N., Newman, M. A., Stivahtis, G., Sharp, P. M., Emerman, M., Hahn, B. H., and Stevenson, M. (1996). Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J. 15, 6155-6165.
15. Foster, J. L., and Garcia, J. V. (2008). HIV-1 Nef: at the crossroads. Retrovirology 22, 84.
16. Fujita, M., Otsuka, M., Miyoshi, M., Khamsri, B., Nomaguchi, M., and Adachi, A. (2008a). Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages. J. Virol. 82, 7752-7756.
17. Fujita, M., Otsuka, M., Nomaguchi, M., and Adachi, A. (2008b). Functional region mapping of HIV-2 Vpx protein. Microbes Infect. 10, 1387-1392.
18. Fujita, M., Otsuka, M., Nomaguchi, M., and Adachi, A. (2010). Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions. Rev. Med.Virol. 20,68-76.
19. Gibbs, J. S., Regier, D. A., and Desrosiers, R. C. (1994). Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses 10, 607-616.
20. Goila-Gaur, R., and Strebel, K. (2008). HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5, 51.
21. Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., de Carvalho, L. P., Stoye, J. P., Crow, Y. J., Taylor, I. A., and Webb, M. (2011). HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480, 379-382.
22. Gramberg, T., Sunseri, N., and Landau, N. R. (2010). Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J. Virol. 84, 1387-1396.
23. Guyader, M., Emerman, M., Montagnier, L., and Peden, K. (1989). VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J. 8, 1169-1175.
24. Hartman, Z. C., Kiang, A., Everett, R. S., Serra, D.,Yang, X. Y., Clay, T. M., and Amalfitano, A. (2007). Adenovirus infection triggers rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J. Virol. 81, 1796-1812.
25. Hirsch, V. M., Sharkey, M. E., Brown, C. R., Brichacek, B., Goldstein, S., Wakefield, J., Byrum, R., Elkins, W. R., Hahn, B. H., Lifson, J. D., and Stevenson, M. (1998). Vpx is required for dissemination and pathogenesis of SIVSMPBj: evi-dence of macrophage-dependent viral amplification. Nat. Med. 4, 1401-1408.
26. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P.,and Skowronski,J. (2011).Vpx relieves inhibition of HIV-1 infec-tion of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661.
27. Jacquot, G., Le Rouzic, E., David, A., Mazzolini, J., Bouchet, J., Bouaziz, S., Niedergang, F., Pancino, G., and Benichou, S. (2007). Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovi-rology 4, 84.
28. Jin, L., Zhou, Y., and Ratner, L. (2001). HIV type 2 Vpx interaction with Gag and incorporation into viruslike particles. AIDS Res. Hum. Retroviruses 17, 105-111.
29. Kappes, J. C., Conway, J. A., Lee, S.W., Shaw, G. M., and Hahn, B. H. (1991). Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Virology 184, 197-209.
30. Kaushik, R., Zhu, X., Stranska, R., Wu, Y., and Stevenson, M. (2009). A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 6, 68-80.
31. Kawamura,M.,Sakai,H.,andAdachi,A. (1994). Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells. Microbiol. Immunol. 38, 871-878.
32. Khamsri, B., Murao, F., Yoshida, A., Sakurai, A., Uchiyama, T., Shirai, H., Matsuo, Y., Fujita, M., and Adachi, A. (2006). Comparative study on the structure and cytopathogenic activity of HIV Vpr/Vpx proteins. Microbes Infect. 8, 10-15.
33. Kitamura, S., Ode, H., and Iwatani, Y. (2011). Structural features of antiviral APOBEC3 proteins are linked to their functional activities. Front. Microbiol. 2:258. doi:10.3389/fmicb.2011.00258
34. Laguette, N., Brégnard, C., Benichou, S., and Basmaciogullari, S. (2010). Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol. Aspects Med. 31, 418-433.
35. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., Yatim, A., Emiliani, S., Schwartz, O., and Benkirane, M. (2011). SAMHD1 is the dendriticand myeloid-cellspecific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657.
36. Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C., Dragin, L., Bloch, N., Maudet, C., Bertrand, M., Gramberg, T., Pancino, G., Priet, S., Canard, B., Laguette, N., Benkirane, M., Transy, C., Landau, N. R., Kim, B., and Margottin-Goguet, F. (2012). SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13, 223-228.
37. Li, N., Zhang, W., and Cao, X. (2000). Identification of human homologue of mouse IFN-γ induced protein from human dendritic cells. Immunol. Lett. 74, 221-224.
38. Lim, E. S., Fregoso, O. I., McCoy, C. O., Matsen, F. A., Malik, H. S., and Emerman, M. (2012). The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11, 194-204.
39. Mahalingam, S., Van Tine, B., Santiago, M. L., Gao, F., Shaw, G. M., and Hahn, B. H. (2001). Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. J. Virol. 75, 362-374.
40. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
41. Nomaguchi, M., Fujita, M., and Adachi, A. (2008). Role of HIV-1 Vpu protein for virus spread and pathogenesis. Microbes Infect. 10, 960-967.
42. Pancio, H. A., Vander Heyden, N., and Ratner, L. (2000). The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells. J. Virol. 74, 6162-6167.
43. Park, I.-W., and Sodroski, J. (1995). Amino acid sequence requirements for the incorporation of the Vpx proteinof simianimmunodeficiency virus into virion particle. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10, 506-510.
44. Planelles, V. (2011). Restricted access to myeloid cells explained. Viruses 3, 1624-1633.
45. Planelles, V., Jowett, J. B., Li, Q. X., Xie, Y., Hahn, B., and Chen, I. S. (1996). Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516-2524.
46. Powell, R. D., Holland, P. J., Hollis, T., and Perrino, F. W. (2011). AicardiGoutieres syndrome gene and HIV1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J. Biol. Chem. 286, 43596-43600.
47. Prehaud, C., Megret, F., Lafage, M., and Lafon, M. (2005). Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79, 12893-12904.
48. Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., Ali, M., Gornall, H., Couthard, L. R., Aeby, A., AttardMontalto, S. P., Bertini, E., Bodemer, C., Brockmann, K., Brueton, L. A., Corry, P. C., Desguerre, I., Fazzi, E., Cazorla, A. G., Gener, B., Hamel, B. C., Heiberg, A., Hunter, M., van der Knaap, M. S., Kumar, R., Lagae, L., Landrieu, P. G., Lourenco, C. M., Marom, D., McDermott, M. F., van der Merwe, W., Orcesi, S., Prendiville, J. S., Rasmussen, M., Shalev, S. A., Soler, D. M., Shinawi, M., Spiegel, R., Tan, T. Y., Vanderver, A., Wakeling, E. L., Wass-mer, E., Whittaker, E., Lebon, P., Stetson, D. B., Bonthron, D. T., and Crow, Y. J. (2009). Mutations involved in Aicardi-Goutières syn-drome implicate SAMHD1 as regu-lator of the innate immune response. Nat. Genet. 41, 829-832.
49. Selig, L., Benichou, S., Rogel, M. E., Wu, L. I., Vodicka, M. A., Sire, J., Benarous, R., and Emerman, M. (1997). Uracil DNA glycosy-lase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunod-eficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71, 4842-4846.
50. Sharifi, H. J., Furuya, A. M., and de Noronha, C. M. (2012). The role of HIV-1 Vpr in promoting the infec-tion of nondividing cells and in cell cycle arrest. Curr. Opin. HIV AIDS 7, 187-194.
51. Sharova, N., Wu, Y., Zhu, X., Stan-ska, R., Kaushik, R., Sharkey, M., and Stevenson, M. (2008). Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restric-tion. PLoS Pathog. 4, e1000057. doi:10.1371/journal.ppat.1000057
52. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
53. Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., and Skowronski, J. (2008). Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 4, e1000059. doi:10.1371/journal.ppat.1000059
54. Stivahtis, G. L., Soares, M. A., Vodicka, M. A., Hahn, B. H., and Emerman, M. (1997). Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol. 71, 4331-4338.
55. Tokunaga, K., Ishimoto, A., Ikuta, K., and Adachi, A. (1997). Growth ability of auxiliary gene mutants of human immunodeficiency virus types 1 and 2 in unstimulated peripheral blood mononuclear cells. Arch. Virol. 142, 177-181.
56. Tsurutani, N., Kubo, M., Maeda, Y., Ohashi, T., Yamamoto, N., Kannagi, M., and Masuda, T. (2000). Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 74, 4795-4806.
57. Ueno, F., Shiota, H., Miyaura, M., Yoshida, A., Sakurai, A., Tatsuki, J., Koyama, A. H., Akari, H., Adachi, A., and Fujita, M. (2003). Vpx and Vpr proteins of HIV2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells. Microbes Infect. 5, 387-395.
58. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., and Guatelli, J. (2008). The interferoninduced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252.
59. Yu, X.-F., Yu, Q.-C., Essex, M., and Lee, T.-H. (1991). The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophages. J. Virol. 65, 5088-5091.
60. Zhao, D., Peng, D., Li, L., Zhang, Q., and Zhang,C. (2008). Inhibition of GIP3 expression found in the different display study on respiratory syncytial virus infection. Virol. J. 5, 114.
61. Zhu, Y., Gelbard, H. A., Roshal, M., Pursell, S., Jamieson, B. D., and Planelles, V. (2001). Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J.Virol. 75, 3791-3801.